Professor Peter Jüni
Professor of Medicine and Clinical Trials
Peter studied medicine at the University of Bern (Switzerland) between 1988 and 1995 and then completed specialist training in General Internal Medicine at various Swiss hospitals. Between 1999 and 2006, he was a research fellow, later a senior research fellow at the Department of Social Medicine at the University of Bristol (UK). After his return to Switzerland, he served as founding director of the University of Bern’s clinical trials unit. In 2010, he was appointed Professor of Clinical Epidemiology and later became Director of the Institute of Social and Preventive Medicine and the Institute of Primary Health Care at the University of Bern.
In 2016, he was appointed Professor of Medicine and Epidemiology at the University of Toronto (Canada), was awarded a Canada Research Chair in Clinical Epidemiology of Chronic Diseases and became Director of the Applied Health Research Centre. Between 2020 and 2022, he served as Scientific Director of the Ontario COVID-19 Science Advisory Table, advising Ontario’s government and informing the public.
Peter’s work has focused on methodological issues and on clinical trials and meta-analyses on the management of cardiovascular and musculoskeletal disorders. He has had leading roles in major cardiovascular trials, including FAME 2 and MATRIX, and co-authored several European guidelines on the management of cardiovascular disease and diabetes. He contributed to more than 500 papers and has been recognised as a highly cited researcher by the Institute for Scientific Information since 2015.
Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort
Soussi S. et al, (2022), Critical Care, 26
Is Internal Rotation Measurement of the Hip Useful for Ruling in Cam or Pincer Morphology in Asymptomatic Males? A Diagnostic Accuracy Study.
Hilfiker R. et al, (2022), Clin Orthop Relat Res, 480, 1989 - 1998
Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials.
Gargiulo G. et al, (2022), Circulation
Cardiovascular meta-analyses: fool's gold or gold for fools?
Biondi-Zoccai G. et al, (2022), European heart journal, 43, 3008 - 3013
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Ono M. et al, (2022), Catheter Cardiovasc Interv, 100, 72 - 82